Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators - The RAID Trial
Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"
Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association
Dapagliflozin for treating chronic heart failure with reduced ejection fraction
Lateral Wall Dysfunction Signals Onset of Progressive Heart Failure in Left Bundle Branch Block
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
Vaccination Trends in Patients With Heart Failure - Insights From Get With The Guidelines–Heart Failure
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.